College of Medicine

Medicine & Life Sciences

1. Neoplasms 100%
2. Therapeutics 80%
3. Multicenter Studies 76%
4. Confidence Intervals 73%
5. Survival 73%
6. Breast Neoplasms 69%
7. Population 62%
8. Recurrence 59%
9. Cohort Studies 59%
10. Odds Ratio 56%
11. Genes 53%
12. Kidney 52%
13. Serum 51%
14. Safety 50%
15. Tomography 50%
16. Lung 50%
17. Stroke 48%
18. Mortality 46%
19. Neoplasm Metastasis 46%
20. Brain 43%
21. Mutation 42%
22. Stomach Neoplasms 42%
23. Elderly 42%
24. Child 41%
25. Chronic Obstructive Pulmonary Disease 41%
26. Mesenchymal Stem Cells 41%
27. Prospective Studies 41%
28. Incidence 41%
29. Breast 40%
30. Retrospective Studies 39%
31. Meta-Analysis 39%
32. Liver 39%
33. Hepatocellular Carcinoma 39%
34. Drug Therapy 39%
35. Radiotherapy 38%
36. Palatine Tonsil 38%
37. Atrial Fibrillation 37%
38. Lymph Nodes 36%
39. Magnetic Resonance Imaging 35%
40. Wounds and Injuries 35%
41. Guidelines 34%
42. Blood Pressure 33%
43. Proteins 33%
44. Colorectal Neoplasms 33%
45. Skin 32%
46. Apoptosis 32%
47. Body Mass Index 31%
48. Seoul 31%
49. Bone and Bones 31%
50. Pain 31%
51. Cognitive Dysfunction 30%
52. Randomized Controlled Trials 29%
53. Phosphorylation 29%
54. Hypertension 29%
55. Endothelial Cells 29%
56. Shoulder 29%
57. Transplants 28%
58. Asthma 28%
59. Alzheimer Disease 28%
60. Non-Small Cell Lung Carcinoma 28%
61. Uric Acid 28%
62. Nutrition Surveys 27%
63. Metabolic Syndrome 27%
64. Biomarkers 27%
65. Survival Rate 27%
66. Registries 27%
67. Single Nucleotide Polymorphism 27%
68. Uterine Cervical Neoplasms 26%
69. Inflammation 26%
70. Infections 26%
71. Chemoradiotherapy 25%
72. Messenger RNA 25%
73. Blood Vessels 25%
74. Genotype 25%
75. Health 25%
76. Pregnancy 25%
77. Parkinson Disease 25%
78. Knee 25%
79. Stomach 25%
80. Regression Analysis 24%
81. Multivariate Analysis 24%
82. Ultrasonography 24%
83. Anti-Inflammatory Agents 24%
84. Obesity 24%
85. Fluorodeoxyglucose F18 24%
86. Injections 24%
87. Lipopolysaccharides 24%
88. Mothers 23%
89. Colonoscopy 23%
90. Biopsy 23%
91. Carcinoma 23%
92. Control Groups 23%
93. Knee Replacement Arthroplasties 23%
94. Serogroup 23%
95. Robotics 23%
96. Liver Transplantation 23%
97. Hip 23%
98. Growth 22%
99. Cytokines 22%
100. Thigh 22%